Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01628094
What this trial is testing

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT00704405
What this trial is testing

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT01343888
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 1)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 656
Testing effectiveness (Phase 2)Study completedNCT01371578
What this trial is testing

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 163
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Post-approval studies (Phase 4)UnknownNCT00370617
What this trial is testing

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Who this might be right for
Chronic Hepatitis CInsulin Resistance
University of Turin, Italy 200
Testing effectiveness (Phase 2)Study completedNCT01609933
What this trial is testing

Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study

Who this might be right for
Chronic Hepatitis C
AbbVie (prior sponsor, Abbott) 32
Testing effectiveness (Phase 2)Study completedNCT03501550
What this trial is testing

Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

Who this might be right for
Chronic Hepatitis C
Cocrystal Pharma, Inc. 12
Post-approval studies (Phase 4)Study completedNCT00107653
What this trial is testing

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 569
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Testing effectiveness (Phase 2)Study completedNCT01051414
What this trial is testing

An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 43
Testing effectiveness (Phase 2)Study completedNCT00963885
What this trial is testing

RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 229
Testing effectiveness (Phase 2)Ended earlyNCT02956629
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 282
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Not applicableStudy completedNCT00724230
What this trial is testing

Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 505
Large-scale testing (Phase 3)Ended earlyNCT01459913
What this trial is testing

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 239
Testing effectiveness (Phase 2)Study completedNCT01025596
What this trial is testing

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)

Who this might be right for
Hepatitis C
Cytheris SA 10
Post-approval studies (Phase 4)WithdrawnNCT02485080
What this trial is testing

Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1

Who this might be right for
PT-NANBH
Stanford University
Post-approval studies (Phase 4)WithdrawnNCT02292966
What this trial is testing

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism

Who this might be right for
Hepatitis C, Chronic
Kirby Institute
Testing effectiveness (Phase 2)Study completedNCT00535847
What this trial is testing

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 117
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation